View Archive »
About The Cover
Molecular docking of DNMT inhibitors to AID. The best insertion model is presented by a ribbon (not shown) and surface model (cover). See Ching-Chow Chen et al.
|
|
Table of Contents
Editorial Materials
|
| Plasticity of melanoma and EMTTF reprogramming |
|
https://doi.org/10.18632/oncotarget.1662
|
| 1-2 |
|
| DNp73: oncotarget in invasion and metastasis |
|
https://doi.org/10.18632/oncotarget.1746
|
| 3-4 |
|
| Breaking Bad: how does a neuronal protein cause neuroendocrine cancer |
|
https://doi.org/10.18632/oncotarget.1710
|
| 5-6 |
|
| A long lasting puzzle for −7/7q− syndrome |
|
https://doi.org/10.18632/oncotarget.1763
|
| 7-8 |
|
| Spherical nucleic acids for precision medicine |
|
https://doi.org/10.18632/oncotarget.1757
|
| 9-10 |
Reviews
|
| Targeting nucleocytoplasmic transport in cancer therapy |
|
https://doi.org/10.18632/oncotarget.1457
|
| 11-28 |
|
| Krüppellike factors in cancer progression: three fingers on the steering wheel |
|
https://doi.org/10.18632/oncotarget.1456
|
| 29-48 |
|
| mTOR pathway in colorectal cancer: an update |
|
https://doi.org/10.18632/oncotarget.1548
|
| 49-66 |
|
| NF2/Merlin in hereditary neurofibromatosis 2 versus cancer: biologic mechanisms and clinical associations |
|
https://doi.org/10.18632/oncotarget.1557
|
| 67-77 |
|
| Perspectives of TGFβ inhibition in pancreatic and hepatocellular carcinomas |
|
https://doi.org/10.18632/oncotarget.1569
|
| 78-94 |
Brief Reports
|
| A novel immunomodulatory and molecularly targeted strategy for refractory Hodgkin’s lymphoma |
|
https://doi.org/10.18632/oncotarget.1468
|
| 95-102 |
|
| The macrophage migration inhibitory factor MIFhomologue Ddopachrome tautomerase is a therapeutic target in a murine melanoma model |
|
https://doi.org/10.18632/oncotarget.1560
|
| 103-107 |
Research Papers
|
| Tumor suppressor genes promote rhabdomyosarcoma progression in p53 heterozygous HER2/neu transgenic mice |
|
https://doi.org/10.18632/oncotarget.1171
|
| 108-119 |
|
| MYCN is a novel oncogenic target in pediatric Tcell Acute Lymphoblastic Leukemia |
|
https://doi.org/10.18632/oncotarget.1337
|
| 120-130 |
|
| A novel androgenregulated isoform of the TSC2 tumour suppressor gene increases cell proliferation |
|
https://doi.org/10.18632/oncotarget.1405
|
| 131-139 |
|
| Genetic subclonal complexity and miR125a5p downregulation identify a subset of patients with inferior outcome in lowrisk CLL patients |
|
https://doi.org/10.18632/oncotarget.1382
|
| 140-149 |
|
| Survivin promoterregulated oncolytic adenovirus with Hsp70 gene exerts effective antitumor efficacy in gastric cancer immunotherapy |
|
https://doi.org/10.18632/oncotarget.1430
|
| 150-160 |
|
| Antitumor activity of the betaadrenergic receptor antagonist propranolol in neuroblastoma |
|
https://doi.org/10.18632/oncotarget.1083
|
| 161-172 |
|
| Chloroquine synergizes with FTS to enhance cell growth inhibition and cell death |
|
https://doi.org/10.18632/oncotarget.1500
|
| 173-184 |
|
| The protooncogene KRAS is targeted by miR200c |
|
https://doi.org/10.18632/oncotarget.1427
|
| 185-195 |
|
| Deficiency in p53 is required for doxorubicin induced transcriptional activation of NFкB target genes in human breast cancer |
|
https://doi.org/10.18632/oncotarget.1556
|
| 196-210 |
|
| AID downregulation is a novel function of the DNMT inhibitor 5azadeoxycytidine |
|
https://doi.org/10.18632/oncotarget.1319
|
| 211-223 |
|
| A TRAF2 binding independent region of TNFR2 is responsible for TRAF2 depletion and enhancement of cytotoxicity driven by TNFR1 |
|
https://doi.org/10.18632/oncotarget.1492
|
| 224-236 |
|
| Genomewide methylation patterns provide insight into differences in breast tumor biology between American women of African and European ancestry |
|
https://doi.org/10.18632/oncotarget.1599
|
| 237-248 |
|
| Overexpression of 1433θ promotes tumor metastasis and indicates poor prognosis in breast carcinoma |
|
https://doi.org/10.18632/oncotarget.1502
|
| 249-257 |
|
| Targeting chronic lymphocytic leukemia using CIGB300 a clinicalstage CK2specific cellpermeable peptide inhibitor |
|
https://doi.org/10.18632/oncotarget.1513
|
| 258-263 |
|
| FOXP3 overexpression inhibits melanoma tumorigenesis via effects on proliferation and apoptosis |
|
https://doi.org/10.18632/oncotarget.1600
|
| 264-276 |
|
| Rac1b negatively regulates TGFβ1induced cell motility in pancreatic ductal epithelial cells by suppressing Smad signalling |
|
https://doi.org/10.18632/oncotarget.1696
|
| 277-290 |
|
| Poly ADPribose polymerase 1 transcriptional regulation: A novel crosstalk between histone modification H3K9ac and ETS1 motif hypomethylation in BRCA1mutated ovarian cancer |
|
https://doi.org/10.18632/oncotarget.1549
|
| 291-297 |
|
| Metformin sensitizes anticancer effect of dasatinib in head and neck squamous cell carcinoma cells through AMPKdependent ER stress |
|
https://doi.org/10.18632/oncotarget.1628
|
| 298-308 |
Copyright © 2026 Rapamycin Press LLC dba Impact Journals
Oncotarget ® is a registered trademark of Rapamycin Press LLC
Impact Journals ® is a registered trademark of Rapamycin Press LLC
RAPAMYCIN PRESS ® is a registered trademark of Rapamycin Press LLC
